Wall Street expects a year-over-year decline in earnings on lower revenues when Moderna (MRNA) reports results for the ...

Moderna (MRNA) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

If you are wondering whether Moderna's share price still reflects its underlying worth, it helps to start with the recent ...

Moderna Inc (NASDAQ:MRNA) shares are trading higher on Wednesday on continued momentum after the company's Tuesday update revealing the long‑term results from a cancer therapy study.

If promising results on a skin cancer vaccine from Moderna and Merck lead to a new launch, the Covid-19 era darling's stock could revive after a 91% fall from its peak.

Moderna shares are down on Monday, pulling back following a recent report highlighting its latest cancer trial results.

Moderna stock rose over 7% after the company and Merck said their personalized melanoma vaccine kept working at five years, cutting recurrence or death risk by 49%.

Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading today, for the November 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options ...

Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading today, for the October 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options ...

MIAMI, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs today announced the launch of the Defiance Daily Target 2X Long MRNA ETF (MRNX), expanding its lineup of single-stock leveraged ETFs designed for ...